Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Dr. Lal PathLabs
LALPATHLAB
Dr. Lal PathLabs
Digital Adoption And Urbanization Will Transform Organized Diagnostics
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 25 Analysts
Published
25 Jul 25
Updated
25 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
₹3,931.00
18.7% undervalued
intrinsic discount
25 Jul
₹3,194.40
Loading
1Y
0.8%
7D
5.6%
Author's Valuation
₹3.9k
18.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
₹3.9k
18.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
37b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue ₹36.7b
Earnings ₹7.4b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
10.64%
Healthcare Services revenue growth rate
0.30%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹7.37b
Earnings '28
x
63.86x
PE Ratio '28
=
₹470.76b
Market Cap '28
₹470.76b
Market Cap '28
/
83.90m
No. shares '28
=
₹5.61k
Share Price '28
₹5.61k
Share Price '28
Discounted to 2025 @ 12.55% p.a.
=
₹3.94k
Fair Value '25